Pediatric hexavalent vaccine (Merck)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePediatric hexavalent vaccine (Merck)
Drug Alias NameHib-DTaP-Hepatitis-B-Poliovirus-vaccine - Merck小儿六价疫苗 - 默克DTP-HepB-Polio-Hib vaccine - MerckVaxelisDTaP5-IPV-Hib-HepB +[8] 
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BVirus DiseasesPoliomyelitis +[9] 
Global Approved IndicationsHepatitis BPoliomyelitisTetanus +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2016/02/15
Country/TerritoryCanadaEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofiMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMcm Vaccine Bv (In Europe)
Inactive CompaniesSanofi PasteurMerck Sharp & Dohme LLCMcm Vaccines Bv
Active IndicationsHepatitis BPoliomyelitisTetanus +[6] 
Inactive IndicationsVirus DiseasesMeningococcal InfectionsBacterial Infections

Other Information

ATC CodeJ07CA09
Related LinksWikipedia